Thomas J. Clement

Tom Clement co-founded Pathway Medical Technologies, Inc. in October 1998 and served as the company CEO until September 2008, leading a talented management team as the company developed and brought to market its flagship product, the jetstream^tm System for treatment of peripheral arteries. As CEO, Clement had active involvement in clinical and regulatory strategy, product development, operations and quality assurance. He was also responsible for business development and financing, where he successfully raised more than $84 million for Pathway. In September, Clement assumed the role of Chairman of the Board. Clement has over 25 years experience in product development engineering, engineering management, and senior management. Previously, Clement was a founding employee of Heart Technology which grew to more than $100 million in revenue and 550 employees. There he spent 12 years in senior management roles. When Heart Technology was acquired by Boston Scientific, Clement became responsible for the emerging cardiovascular technologies group of the Scimed Division. Clement has a Master of Science in Electrical Engineering from the University of Washington. Currently he serves as Chairman of the Board of Directors for the Washington Biotechnology and Biomedical Association (WBBA), and he has positions on the Visiting Committee for the University of Washington Educational Outreach Programs, the Advisory Board to the University of Washington’s Master Degree in Medical Engineering, and the Advisory Board to the University of Washington / Bothell Business Administration programs.

John F. Harris

John F. Harris is NeuroVista’s President and CEO and brings more than 20 years of experience successfully developing and commercializing innovative medical device technologies. Prior to joining NeuroVista in December of 2004, John was an Executive in Residence at Versant Ventures, a healthcare-dedicated venture capital firm, providing consulting on early-stage medical device opportunities. Prior to Versant Ventures, John was a founder and the Vice President of Marketing and Business Development for Northstar Neuroscience, Inc., a Seattle-based medical device company seeking to improve neurological recovery following stroke through targeted electrical stimulation of the brain. Prior to co-founding Northstar, John was a founder of Heartstream, a Seattle-based company that revolutionized the treatment of sudden cardiac arrest with uniquely designed external defibrillators that make the deployment of these devices practical in a variety of settings. In addition to his founding role, John was a member of the executive team responsible for guiding the company through formation, product development, venture financing, Food and Drug Administration (FDA) clearance, product launch, manufacturing scale-up, an initial public offering, worldwide sales and distribution, and the sale of the company to Hewlett-Packard. The company is now owned by Philips Medical Systems. Prior to co-founding Heartstream, John held engineering and marketing positions at Physio-Control and ROLM Corporation. John received a BS in industrial engineering from Stanford University and an MBA from Northwestern University’s Kellogg School of Management.

Douglas Swartz

Mr. Douglas Swartz has extensive experience in the technical development, and financial and business requirements necessary for companies to succeed. Mr. Swartz has over 25 years of experience in the creation of technology start-ups, and personally founded and led four tech firms. These firms (Integrated Solutions, Outbound Systems, Black Labs, and Ntrapoint) represent advances in diverse fields and several reached liquidity. His first venture, Integrated Solutions, was a company which designed and manufactured UNIX servers and workstations for corporate users. He grew that company to $6 million in sales within three years at which time it was acquired for in excess of $8 million (1985 dollars). His second company, Outbound Systems, was formed to capitalize on opportunities in portable computing. This company was sold to Apple Computer. In addition to his entrepreneurial ventures, Mr. Swartz has twenty-eight years of experience in technology companies, primarily in management roles. He has helped lead companies to success in all phases of product development from concept to launch. Mr. Doug Swartz earned his B.S. and M.S. Degrees in Electrical Engineering from Rensselaer Polytechnic Institute, worked towards a Ph.D. in Electrical Engineering at Stanford University (1973), and earned his M.B.A. from Northeastern University (1979).

Justin Hulvershorn, MD, PhD

Dr. Justin Hulvershorn served recently as Director of Research at Northstar Neuroscience. Justin has an extensive clinical background, and experience running both small and large clinical trials in the US and in Europe. He is an author on 12 peer reviewed journal articles and inventor on over 30 patent disclosures relating to cortical stimulation for CNS disorders.  Justin is the primary inventor of Mirador’s core technology platform.  Justin graduated Summa Cum Laude from the University of Virginia with a B.S. in Engineering Science, and received a Ph.D. in Biophysics and M.D. from the University of Pennsylvania.

Karl Schmidt

Mr. Karl Schmidt most recently led Global Marketing at Northstar Neuroscience where he was responsible for marketing and clinical trial recruitment in the USA and Germany. Karl has worked in the medical device industry for the past 15 years and has held roles in manufacturing, R&D, marketing and public relations for companies such as Boston Scientific, Bayer, and BVMED. Prior to Northstar, Karl worked for Boston Scientifics’ Electrophysiology Division where he managed 3 product launches and a market leading $70 million dollar product line. Before joining BSC Karl was awarded the Bosch Fellowship and worked in Germany on improving transatlantic collaborations to bring medical technologies to market more effectively.   Karl holds an M.B.A, B.S in Chemical Engineering, and a BA in German Literature from the University of Washington.